{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:14:30Z","timestamp":1791688470780,"version":"4.3.4"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Primary sclerosing cholangitis\/autoimmune hepatitis (PSC\/AIH) and primary biliary cirrhosis\/AIH (PBC\/AIH) overlap syndromes are poorly defined variants of AIH. Few large patient series exist, and there are little data on long\u2010term outcomes.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To compare presentation, clinical course and outcome of patients with PSC\/AIH and PBC\/AIH, with patients with definite AIH.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Two hundred and thirty\u2010eight AIH patients were compared with 10 PBC\/AIH patients and 16 PSC\/AIH patients presenting consecutively between 1971 and 2005 at a single centre.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Autoimmune hepatitis patients were significantly more likely to present with jaundice (69.4% vs. 25%; <jats:italic>P<\/jats:italic>\u2003=\u20030.0145) than PBC\/AIH patients. Median serum aspartate aminotransferase activity at presentation was higher in AIH patients compared with PBC\/AIH and PSC\/AIH patients respectively (620 vs. 94 vs. 224\u2003IU\/L; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). PBC\/AIH patients demonstrated no response to standard AIH therapy more frequently than AIH patients (25% vs. 0.8%; <jats:italic>P<\/jats:italic>\u2003=\u20030.0057). Significant reduction in survival was identified between patients with PSC\/AIH and those without (hazard ratio: PSC\/AIH vs. AIH\u2003=\u20032.08, PSC\/AIH vs. PBC\/AIH\u2003=\u20032.14; <jats:italic>P<\/jats:italic>\u2003=\u20030.039).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Patients with PSC\/AIH have severe disease and significantly worse prognosis than patients with AIH or PBC\/AIH. Recognition and close follow\u2010up of this cohort are warranted.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2008.03722.x","type":"journal-article","created":{"date-parts":[[2008,10,12]],"date-time":"2008-10-12T09:05:49Z","timestamp":1223802349000},"page":"209-220","source":"Crossref","is-referenced-by-count":128,"title":["Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long\u2010term outcome and survival"],"prefix":"10.1111","volume":"28","author":[{"given":"T.","family":"AL\u2010CHALABI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"PORTMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"BERNAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. G.","family":"MCFARLANE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"HENEGHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00019-3"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.23316"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05419-6"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280203"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280210"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80004-5"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199512000-00007"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331502"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180435"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2004.03372.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30902"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05703.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/0891693021000064272"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200406000-00012"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41841.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.224_a.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80266-2"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360615"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.017"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21229"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00029330-200602010-00013"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290409"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.01.009"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20235"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080414"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91329-7"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2008.03722.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2008.03722.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T15:43:31Z","timestamp":1697211811000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2008.03722.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1365-2036.2008.03722.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03722.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}